Consort Medical PLC Director Declaration (6279P)

TIDMCSRT

RNS Number : 6279P

Consort Medical PLC

01 September 2017

Consort Medical plc

Director Declaration

In accordance with Rule 9.6.14 of the UK Listing Rules, Consort Medical plc ('the Company') gives notice that Ms Charlotta Ginman, a non-executive Director of the Company, has been appointed a non-executive Director of Keywords Studios plc with effect from 1 September 2017.

Enquiries:

 
 Consort Medical plc Tel: [phone] 
  John Ilett - Company Secretary 
 Consort Medical plc is a leading, global, 
  single source drug and delivery device company 
  (CDMO). We are at the leading edge of innovation 
  and we are committed to investing in patient, 
  clinician and customer driven innovation 
  to create new treatments, new markets and 
  new opportunities. 
  Our businesses 
  Bespak is a global market leader in the manufacture 
  of drug delivery devices for pharmaceutical 
  partner companies, including respiratory, 
  nasal, and injectable products, and the manufacture 
  of devices for the point of care diagnostics 
  market. www.bespak.com. 
  Aesica is a leading provider of finished 
  dose and active pharmaceutical ingredient 
  (API) development and manufacturing services 
  to pharmaceutical partners. www.aesica-pharma.com. 
  We employ more than 2,000 people globally 
  of which 1,400 are located in the UK. We 
  have UK facilities in King's Lynn, Cambridge, 
  Nelson, Milton Keynes, Cramlington, Queenborough 
  and Hemel Hempstead, German facilities in 
  Monheim and Zwickau and a facility in Pianezza, 
  Italy. Consort Medical is a public company 
  quoted on the premium list of the London 
  Stock Exchange (LSE: CSRT). www.consortmedical.com. 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDNEADNFELKXEFF

(END) Dow Jones Newswires

September 01, 2017 09:47 ET (13:47 GMT)